Programming skills in 2026 are no longer limited to software engineers. From data analysis and automation to AI, cybersecurity, and product development, programming has become a foundational skill ...

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

Editor's note: Follow Olympics figure skating live results and updates from 2026 Winter Games. Ilia Malinin will be on the ice for the final day of the team event Sunday, Feb. 8, performing the men's ...

Five days into the desperate search for 84-year-old Nancy Guthrie, investigators on Thursday released a detailed timeline from the hours before and after the disappearance of Guthrie, who is the ...

I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness/fitness myths. In my free time I enjoy ...

A 96-year-old’s $2M dream vanished after a fake Publishers Clearing House letter nearly swindled the South Florida senior in a sophisticated sweepstakes scam. Cuban community rallies near Mar-a-Lago ...

As the year comes to a close, Jessica Scanlon, founder of Hot Dog Marketing, can already cross one item off of her 2026 to-do list: renewing her Historically Underutilized Business program status.

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Send a note to Doug Wintemute, Kara Coleman Fields and our other editors. We read every email. By submitting this form, you agree to allow us to collect, store, and potentially publish your provided ...

My little theory is that the concept of “imprinting” in psychology can just as easily be applied to programming: Much as a baby goose decides that the first moving life-form it encounters is its ...

Management reaffirmed guidance for 2025 on an expense base of less than $450 million, "excluding all of the partnership inflows." For 2026, guidance was also reaffirmed at less than $390 million.

remove-circle Internet Archive's in-browser video "theater" requires JavaScript to be enabled. It appears your browser does not have it turned on. Please see your ...